BridgeMD
New treatment option for Blood Stream Infections
Official title EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
ClinicalTrials.gov ID: NCT05979545
What this study is testing
- What it's testing
- The goal of this clinical trial is to propose a seamless intervention linking rapid bacterial isolate identification and antibiotic resistance gene detection and targeted antibiotic prescription to minimise time between infection onset and appropriate treatment in patients with Pseudomonas aeruginosa or carbapenemase producing Enterobacterales infections. This is an investigator initiated trial.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- patient developed clinical symptoms compatible with bloodstream infection, hospital-acquired or ventilator-associated pneumonia (hospital-acquired...
- an appropriate specimen has been received by the participating laboratory - that is, a blood culture bottle showing Gram negative bacilli or a...
You likely can't join if
- Refractory shock or comorbid condition such that patient not expected to survive more than 48 hours; OR,
- where the bloodstream infection is thought to be related to a vascular catheter and the catheter is unable to be removed; OR,
- treatment is not with the intent to cure the infection; OR,
- patient is incarcerated in a correctional facility; OR,
- patients previously assigned by chance in this trial within the last 60 days.
The study team makes the final eligibility decision.
Where it's taking place
- Kuala Lumpur, Malaysia
- Taichung, Xitun District, Taiwan
- Kaohsiung City, Taiwan
- Ubon Ratchathani, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kuala Lumpur, Malaysia; Taichung, Xitun District, Taiwan; Kaohsiung City, Taiwan; Ubon Ratchathani, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.